Skip to main content
    R

    Rapid Micro Biosystems Inc (RPID)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.87
    -0.01 (-0.57%)

    Market Cap: $43.31M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    29%(6/21)
    Avg Surprise
    -239.56%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.20
    Range$-0.21 - $-0.19
    4 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.20-1.3%
    60d ago$-0.20-1.3%
    30d ago$-0.20-1.3%
    7d ago$-0.20-1.3%
    Current$-0.20
    Revenue Consensus
    $10M
    Range$9M - $11M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.25
    Range$-0.27 - $-0.22
    4 analysts
    Revenue Consensus
    $14M
    Range$13M - $15M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.25---
    Sep 26EST
    		-$-0.20---
    Jun 26
    Reported Aug 7
    		$-0.27$-0.26-3.85%Miss+0.0%
    Mar 26
    Reported May 13
    		$-0.31$-0.21-47.62%Miss-19.2%
    Dec 25
    Reported Mar 12
    		$-0.28$-0.23-21.74%Miss-27.3%
    Sep 25
    Reported Nov 7
    		$-0.26$-0.24-8.33%Miss+0.0%
    Jun 25
    Reported Aug 12
    		$-0.27$-0.25-8.00%Miss+6.9%
    Mar 25
    Reported May 9
    		$-0.26$-0.27+3.70%Beat+16.1%
    Dec 24
    Reported Feb 28
    		$-0.22$-0.21-4.76%Miss+15.4%
    Sep 24
    Reported Nov 1
    		$-0.26$-0.25-4.00%Miss+16.1%
    Jun 24
    Reported Aug 2
    		$-0.29$-0.28-3.57%Miss+12.1%
    Mar 24
    Reported May 3
    		$-0.31$-0.29-6.90%Miss+3.1%
    Dec 23
    Reported Mar 1
    		$-0.26$-0.30+13.33%Beat+33.3%
    Sep 23
    Reported Nov 3
    		$-0.31$-0.28-10.71%Miss+18.4%
    Jun 23
    Reported Aug 4
    		$-0.33$-0.33+0.00%Beat-6.5%
    Mar 23
    Reported May 5
    		$-0.32$-0.36+11.11%Beat+8.6%
    Dec 22
    Reported Mar 3
    		$-0.39$-0.36-8.33%Miss-11.4%
    Sep 22
    Reported Nov 10
    		$-0.38$-0.36-5.56%Miss+2.6%
    Jun 22
    Reported Aug 12
    		$-0.31$-0.35+11.43%Beat+98.5%
    Mar 22
    Reported May 10
    		$-0.35$-0.32-9.38%Miss+49.3%
    Dec 21
    Reported Mar 4
    		$-0.35$-0.28-25.00%Miss-
    Sep 21
    Reported Nov 11
    		$-0.39$-0.39+0.00%Beat-
    Jun 21
    Reported Jul 16
    		$-20.01$-0.40-4902.50%Miss-
    Mar 21
    Reported Jun 2
    		$-0.69$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.78EV/EBITDAN/A
    Price/FCF-1.03xFCF Yield-96.67%
    Profitability
    Profit Margin-145.60%Operating Margin-153.00%
    ROE-141.70%ROIC-135.11%
    Financial Health
    Debt/Equity1.08xInterest Coverage-21.20x
    Current Ratio2.55xQuick Ratio1.51x
    Trading Statistics
    Beta1.50Avg Volume317.61K
    52-Week High$4.9452-Week Low$0.81

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.92
    SMA 20$1.01
    SMA 50$1.35
    SMA 200$2.39
    EMA 10$0.93
    EMA 20$1.02
    EMA 50$1.29
    EMA 200$2.09

    MACD

    Line: -0.13Signal: -0.14Hist: 0.01

    ADX

    ADX: 29.2+DI: 14.8-DI: 27.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down88.0
    PSAR$1.13

    Bollinger Bands

    Upper Band$1.22
    Lower Band$0.81
    %B Position4121%(Upper)
    Band Width0.16

    RSI (14-Day)

    Oversold
    23.7

    Momentum Oscillators

    Stoch %K15.6
    Stoch %D14.4
    Williams %R-86.4
    ROC (10d)-19.1%
    Momentum-0.21
    CCI (20d)-107.4
    MFI (14d)21.6

    Volatility Measures

    ATR (14d)$0.09(10.6%)
    StdDev (20d)0.10
    Hist Vol56.4%(High)

    Volume Flow

    VWAP$0.87
    OBV-7.1M
    AD Line-8.0M
    CMF (20d)-0.605

    Volume Metrics

    Avg Vol (20d)330.1K
    Vol Ratio0.5x
    VWMA (20d)$1.04

    Pivot Points

    R3$0.94
    R2$0.92
    R1$0.90
    Pivot Point$0.88
    S1$0.86
    S2$0.83
    S3$0.81

    Advanced Oscillators

    TSI-56.14
    Ultimate Osc27.4
    KST-301.93

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$8.05M$8.00M$11.28M$7.84M$7.26M$7.21M$8.22M$7.60M$6.62M$5.61M$6.34M$6.14M
    Cost of Revenue$6.84M$7.63M$11.61M$7.14M$6.99M$6.80M$7.24M$6.98M$6.81M$7.13M$6.51M$7.78M
    Gross Profit$1.21M$371,000$-328,000$696,000$275,000$404,000$981,000$622,000$-189,000$-1,523,000$-172,000$-1,631,000
    Operating Expenses$13.53M$14.22M$11.88M$12.07M$12.42M$12.06M$11.21M$12.66M$13.19M$12.75M$12.02M$12.82M
    R&D$3.33M$3.36M$3.22M$3.53M$3.23M$3.62M$3.40M$3.61M$3.74M$3.84M$3.32M$3.12M
    SG&A$6.77M$7.44M$5.34M$5.64M$6.08M$5.69M$4.83M$5.68M$5.82M$5.63M$5.54M$6.20M
    Operating Income$-12,322,000$-13,852,000$-12,211,000$-11,372,000$-12,148,000$-11,661,000$-10,229,000$-12,039,000$-13,378,000$-14,273,000$-12,188,000$-14,449,000
    Interest Income$140,000$256,000$345,000$347,000$351,000$466,000$604,000$779,000$838,000$983,000$0$1.09M
    Interest Expense$646,000$639,000$272,000$393,000$12,000$12,000$0$11,000$0$0$0$0
    Income Before Tax$-12,878,000$-14,267,000$-12,483,000$-11,497,000$-11,847,000$-11,256,000$-9,675,000$-11,310,000$-12,563,000$-13,319,000$-11,164,000$-13,382,000
    Income Tax Expense$45,000$8,000$14,000$8,000$11,000$7,000$-9,000$13,000$15,000$3,000$8,000$10,000
    Net Income$-12,923,000$-14,275,000$-12,497,000$-11,505,000$-11,858,000$-11,263,000$-9,666,000$-11,323,000$-12,578,000$-13,322,000$-11,172,000$-13,392,000
    EBITDA$-11,613,000$-13,092,000$-11,341,000$-10,647,000$-11,375,000$-10,863,000$-9,381,000$-11,219,000$-12,573,000$-13,496,000$-11,411,000$-13,694,000
    EBIT$-12,372,000$-13,884,000$-12,131,000$-11,451,000$-12,186,000$-11,710,000$-10,250,000$-12,078,000$-13,401,000$-14,302,000$-12,205,000$-14,475,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RPID

    Government Contracts

    Gov Obligations (TTM)
    $39051
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    4.9 mo

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    HT942626FE009Department of DefenseDefense Health Agency$39051Feb 9, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Roth Capital Partners Initiates Rapid Micro Biosystems at Buy

    Roth Capital Partners has initiated coverage of Rapid Micro Biosystems with a "Buy" rating. The company, which specializes in automated microbial quality control detection for pharmaceutical products...

    marketscreener.com•9/29/26•Bullish

    Roth/MKM initiates Rapid Micro Biosystems stock with buy rating By Investing.com

    Roth/MKM has initiated coverage on Rapid Micro Biosystems Inc. (NASDAQ:RPID) with a Buy rating and a $3.00 price target...

    Investing.com Nigeria•9/29/26•Bullish

    Armistice Capital (RPID) discloses 3.33M-share position in Rapid Micro Biosystems

    Armistice Capital, LLC and Steven Boyd have disclosed a 7.29% stake in Rapid Micro Biosystems, Inc. (RPID), amounting to 3,328,000 shares of Class A common stock. All voting and dispositive power over these shares is...

    Stock Titan•8/14/26•Neutral

    Rapid Micro Biosystems (RPID) major holder Bain updates Schedule 13G/A stake

    Bain Capital Life Sciences-affiliated funds have updated their stake in Rapid Micro Biosystems (RPID) Class A common stock through a Schedule 13G/A filing. As of June 30, 2026, Bain Capital Life Sciences Fund...

    Stock Titan•8/14/26•Neutral

    Rapid Micro Biosystems, Inc. (RPID) Leadership & Management Team Analysis

    This article provides an in-depth analysis of Rapid Micro Biosystems, Inc. (RPID)'s leadership, management team, and recent company updates. It highlights CEO Rob Spignesi's compensation and ownership...

    Simply Wall Street•8/8/26•Somewhat-Bearish

    RPID Valuation and Fair Value

    P/E
    -0.8x
    P/FCF
    -1.0x
    PEG
    0.0x
    P/B
    2.4x
    See GNG's fair value

    RPID Profitability: Margins, ROIC and FCF

    Gross margin
    5.5%
    Operating margin
    -153.0%
    Net margin
    -145.6%
    ROIC
    -135.1%
    ROE
    -141.7%
    FCF margin
    -116.1%
    FCF yield
    -96.7%

    RPID Competitors

    CompanyTicker
    Serina Therapeutics IncSER
    Dogwood Therapeutics, Inc.DWTX
    INmune Bio IncINMB
    eXoZymes, Inc.EXOZ
    Xtant Medical Holdings IncXTNT
    Tevogen Bio Holdings Inc.TVGN
    Celularity IncCELU
    PureTech Health PLCPRTC

    Sector: Healthcare

    RPID Analyst Ratings

    Consensus
    Buy
    Analysts
    4
    Strong Buy
    0
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0

    RPID Bull Case vs Bear Case

    Bull case

    • RPID grew quarterly revenue 10.9% year over year.

    Bear case

    • RPID has a -145.6% net profit margin.
    • RPID beat EPS estimates in 12.5% of its last 8 reported quarters.

    RPID Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -11.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.20
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 1 down

    Frequently Asked Questions About RPID

    Does RPID pay dividends?

    Rapid Micro Biosystems Inc (RPID) does not currently pay a regular dividend.

    What is RPID's market cap?

    Rapid Micro Biosystems Inc (RPID) has a market capitalization of $43.31M with a current stock price of $0.87.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In